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Campylobacteriosis is one of the most common causes of bacterial gastroenteritis.
However, the clinical course of the illness varies in symptoms and severity. The
aim of this study was to characterize Campylobacter jejuni (34 isolates) and C. coli
(9 isolates) from persons with diarrheal and non-diarrheal stools at the time of
examination and fecal sampling, in Poland by using whole-genome sequencing (WGS).
Multilocus sequence typing (MLST) analysis revealed a high diversity with a total
of 20 sequence types (STs) among 26 Campylobacter isolates from diarrheic and
13 STs among 17 isolates from non-diarrheic persons. ST-50 and ST-257 were
most common in both groups. The phenotypic resistance rate was 74.4% for
ciprofloxacin, 67.4% for sulfamethoxazole/trimethoprim, 58.1% for amoxicillin, 48.8%
for tetracycline, and 46.5% for ceftriaxone. Only single isolates were resistant to
erythromycin, gentamicin, and amoxicillin/clavulanic acid. Overall genotypic resistance
toward amoxicillin, fluoroquinolones, tetracyclines, and aminoglycosides was predicted
to occur in 93.1, 67.4, 48.8, and 11.6% of the isolates, respectively. None of the isolates
showed the presence of the erm(B) gene or mutation in 23S rRNA. Neither was variation
found in the important target region in L4 and L22 ribosomal proteins. In regard to
the CmeABC efflux pump, a set of variable mutations affecting the regulatory region
was noted. All Campylobacter isolates possessed genes associated with adhesion
(cadF, jlpA, porA, and pebA) and invasion (ciaB, pldA, and flaC). The type IV secretion
system (T4SS) was found in isolates from both diarrheic (15.4%, CI 95%: 6.1–33.5%)
and non-diarrheic (23.5%, CI 95%: 9.6–47.3%) persons. The rates of the presence of
cytolethal distending toxin cdtABC gene cluster and type VI secretion system (T6SS)
were higher in Campylobacter isolates obtained from persons with diarrhea (96.2%,
CI 95%: 81.7–99.3% and 26.9%, CI 95%: 13.7–46.1%) compared to isolates from
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non-diarrheic persons (76.5%, CI 95%: 52.7–90.4% and 11.8%, CI 95%: 3.3–34.3%).
The lack of statistically significant differences between two groups in tested virulence
factors suggests that individual susceptibility of the host might play more determining
role in the disease outcome than characteristics of the infecting strain.
Keywords: Campylobacter, foodborne pathogen, diarrhea, antimicrobial resistance, virulence factors
INTRODUCTION
Campylobacteriosis is the most commonly reported cause
of human bacterial gastroenteritis. In 2018, the number of
reported cases in the EU was 246,571, whereas salmonellosis
and yersiniosis were confirmed, respectively, in 91,857 and
6,699 cases (European Food Safety Authority [EFSA], 2019).
Poultry and poultry meat are considered as one of the main
reservoirs and sources of human Campylobacter infections.
In addition, a broad range of other animals, such as cattle
and swine can harbor these bacteria in their digestive track
(Wysok et al., 2015). Also, contact with dogs and cats is
considered as a risk factor for human campylobacteriosis
(Andrzejewska et al., 2013).
Persons infected with Campylobacter usually manifest the
symptoms including gastroenteritis with bloody or mucoid
diarrhea (Allos, 2001). Also, extragastrointestinal manifestations
such as bacteremia, meningitis, and reactive arthritis may
occur especially in immunocompromised individuals (Kaakoush
et al., 2015). However, Allos (2001) underlined that in some
patients, abdominal pain without diarrhea is the predominant
feature. According to Janssen et al. (2008), in 30% of patients,
campylobacteriosis does not start with diarrhea but with a
prodrome of influenza virus-like symptoms such as fever,
headache, dizziness, and myalgia. Both bacterial virulence
factors and host susceptibility factors are thought involved in
determining the disease outcome.
Multiple bacterial factors have been implicated in the
pathogenesis of campylobacteriosis including adhesion, invasion,
and production of certain toxins, which support Campylobacter
to invade the host, cause disease, and evade host defense (de
Oliveira et al., 2019). Identification of virulence factors involved
in the pathogenesis of campylobacteriosis is crucial to better
understanding the mechanisms of the infection and to identify
if certain, potentially more virulent strains exist.
In most cases, the illness requires no specific antimicrobial
treatment. However, in severe cases antimicrobial therapy and
hospitalization may be needed (Allos, 2001; Wieczorek and Osek,
2013). The average hospitalization rate in the EU countries
has been 30.5%, but in Poland, Latvia, Romania, and the
United Kingdom, very high hospitalization rates from 80 to
100% have been noted (European Food Safety Authority [EFSA],
2017). Macrolides, such as erythromycin and azithromycin, are
the most commonly used antimicrobial agents in the treatment
of campylobacteriosis. Fluoroquinolones, tetracyclines, and
aminoglycosides are also choices in the treatment (Wieczorek
and Osek, 2013). However, growing antimicrobial resistance
is a global issue. According to the monitoring protocol of
Center for Disease Control and Prevention, Campylobacter
isolates of human origin should be tested for resistance to
antibiotics such as ciprofloxacin, erythromycin, tetracycline,
and gentamicin (Center for Disease Control and Prevention
[CDC], 2018). Resistance to antimicrobial agents can be
tested phenotypically or predicted by sequence-based methods
(Su et al., 2019).
Studies showing clonal relationship between strains are very
important to trace the sources and routes of transmission and
improve the robustness of epidemiological association studies
(Kovanen et al., 2014). MLST is a commonly used method
for analyzing the molecular epidemiology of Campylobacter
(Dingle et al., 2001). Presently, whole-genome sequencing
(WGS) is considered to be a superior and increasingly available
method for molecular subtyping and comprehensive comparative
genomic analyses, providing information also on the antibiotic
resistance profiles and presence of virulence factors among
strains (Kovanen et al., 2014, 2016; Llarena et al., 2017). Recent
studies have highlighted the value of WGS in monitoring the
antimicrobial resistance (AMR) patterns in Campylobacter. High
concordance (97.5%) was shown to occur between the presence
of AMR determinants in WGS data and phenotypic resistance
among 528 C. jejuni and C. coli isolates from England and Wales
(Painset et al., 2020). Similar results were recently reported from
Latvia (Meistere et al., 2019).
In this study, we applied WGS to determine the diversity of
Campylobacter strains obtained from humans with and without
diarrhea. In order to test the hypothesis that genetic differences
exist between the two groups of isolates, we studied the genotypes
and presence of certain known virulence factors among the
isolates. Furthermore, we compared the MIC levels for eight
antimicrobial agents with genotypic resistance profiles.
MATERIALS AND METHODS
Bacterial Strains
A total of 43 epidemiologically unrelated Campylobacter
isolates were included in the study. The human isolates were
obtained from the regional sanitary—epidemiological units and
from the diagnostic microbiology laboratory strain collections
from northeastern Poland from 2011 to 2013. The isolates
were originally recovered from routine stool samples, and
all samples were anonymized. Twenty six Campylobacter
isolates were obtained from persons with diarrheal stools
routinely examined for the presence of enteric pathogens.
Seventeen isolates were acquired from persons diagnosed
with symptoms like abdominal pain but without signs of
loose stool up to the time of examination and fecal sampling.
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All fecal samples were bacteriologically examined at the
request of a physician. Campylobacter spp. were isolated
from the fecal samples using modified charcoal cefoperazone
deoxycholate agar (mCCDA) (Oxoid, United Kingdom)
incubated under microaerobic conditions at 41 ± 1◦C for 48 h.
Characteristic colonies were confirmed as belonging to the
genus Campylobacter in accordance with ISO 10272-1, 2017. All
collected Campylobacter isolates were sent to the Department
of Food Hygiene and Environmental Health of University of
Helsinki for further analyses.
DNA Isolation
The isolates were cultivated on mCCDA plates (Oxoid,
United Kingdom). After incubation, typical colonies were Gram
stained. DNA was extracted from pure cultures grown on nutrient
blood agar microaerobically at 37◦C for 24 h, using the PureLink
Genomic DNA Mini Kit (Invitrogen, United States) according
to the manufacturer’s instructions. Quantification was performed
using the Qubit fluorometer (Life Technologies, Invitrogen, CA,
United States). Prior to WGS analysis, DNA was stored at−20◦C.
Genome Sequencing, Assembly, MLST,
and Phylogenetic Analyses
Whole-genome sequencing was performed at the Institute for
Molecular Medicine Finland (FIMM) using Nextera DNA Flex
Library Prep Kit and Illumina HiSeq or MiSeq. The raw sequence
reads were deposited in GenBank under BioProject Accession
number PRJNA549025.
A docker image of INNUca v.4.2.0-03, INNUENDO pipeline
for quality control of reads, de novo assembly, and contigs quality
assessment (Machado et al., 2019) was used to assemble draft
genomes from the raw reads and to determine the sequence
types (STs) of the Campylobacter isolates. Novel alleles and
STs were submitted to the Campylobacter MLST database1.
Prokka (Seemann, 2014) was used for annotating the genomes.
Then, Roary (Page et al., 2015) was used to generate the core
gene alignments and FastTree (Price et al., 2010) to infer the
approximately maximum-likelihood phylogenetic tree based on
the core gene alignments using the generalized time-reversible
(GTR) model of nucleotide evolution. Jobs were run in parallel
using GNU Parallel (Tange, 2011). The trees (rooted at midpoint)
were visualized using iToL v42 (Letunic and Bork, 2016).
Campylobacter isolates obtained in this study were compared
with MLST allele sequences of all Campylobacter isolates from
different sources including poultry, swine, and cattle from Poland
available at PubMLST database3 and from previous publications
(Wieczorek et al., 2017; Wieczorek and Osek, 2018; Fiedoruk
et al., 2019). A neighbor-joining tree was constructed based on
the concatenated seven-locus MLST sequence and visualized with
iTOL v4 (see text footnote 2) (Letunic and Bork, 2016).
Antimicrobial Susceptibility Testing
The antimicrobial susceptibility was determined by the E-test
according to the protocol of the European Committee on
1https://pubMLST.org/campylobacter/
2http://itol.embl.de
Antimicrobial Susceptibility Testing (EUCAST) for fastidious
organisms. C. jejuni ATCC 33560 was used for quality
control. All Campylobacter isolates were suspended into
Brain Heart Infusion (BHI) broth to a turbidity equivalent
to a 0.5 McFarland standard. Mueller–Hinton agar plates
supplemented with 5% of defibrinated horse blood (Oxoid)
and 20 mg/L β-NAD (Sigma Aldrich) were inoculated with
the suspension prepared. The following M.I.C.Evaluator
(Oxoid) strips were placed on the surface of dry plates:
erythromycin (E, 0.015–256 µg/ml), gentamicin (CN, 0.015–
256 µg/ml), ciprofloxacin (CIP, 0.002–32 µg/ml), amoxicillin
(AML, 0.015–256 µg/ml), tetracycline (TET, 0.015–256 µg/ml),
amoxicillin/clavulanic acid (AMC, 0.015–256 µg/ml), ceftriaxone
(CRO, 0.002–32 µg/ml), and trimethoprim/sulfamethoxazole
(SXT, 0.002–32 µg/ml). The plates were incubated at
41 ± 1◦C for 24–48 h at microaerophilic atmosphere.
Zones of inhibited growth for erythromycin, ciprofloxacin,
and tetracycline were determined according to EUCAST
breakpoints for Campylobacter3. Since the MIC breakpoints
for the remaining tested antimicrobials were not specified
for Campylobacter by EUCAST, we used the breakpoints for
Enterobacteriaceae.
Identification of Resistance and
Virulence Genes
Identification of genes encoding resistance to tetracyclines,
β-lactams, aminoglycosides, macrolides, and fluoroquinolones
in the draft Campylobacter genomes was performed using both
ResFinder (Zankari et al., 2012) and Comprehensive Antibiotic
Resistance Database (CARD) (Jia et al., 2017) as well as the Rapid
Annotation using Subsystem Technology (RAST) web server
(Aziz et al., 2008; Overbeek et al., 2014). The blaOXA61-positive
isolates were screened toward the single-nucleotide mutation
(transversion G → T) in the promoter region of the target
gene (Zeng et al., 2014). NCBI blast tools were used to compare
nucleotide sequences.
The occurrence of genes associated with adherence (cadF,
jlpA, porA, and pebA), invasion (ciaB, flaC, and pldA), cytolethal
distending toxin (cdtA, cdtB, and cdtC), T4SS (virB11, virB10,
virB9, virB8, virB7, virB6, virB5, virB4, and virD4) and T6SS
(tssA, tssB, tssC, hcp, tssE, tssF, tssG, tagH, vgrG, tssJ, tssK,
tssM, and tssL) were determined using RAST and NCBI BLAST
searches. The sequences were compared against the reference
genomes of C. jejuni (strain NCTC 11168) and C. coli (strain
OR12). The presence of a gene was established using a 90%
similarity threshold.
Statistical Analysis
Statistical tests were performed using Statistica (StatSoft, version
13.3). Comparisons between the prevalence of resistance and
virulence determinants among Campylobacter isolates from
diarrheic and non-diarrheic persons were performed using
the Fisher’s exact test. Statistical significance was defined as
P < 0.05.
3https://eucast.org/clinical_breakpoints/
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FIGURE 1 | Phylogenetic analysis of C. jejuni and C. coli isolates from diarrheic and non-diarrheic persons based on their core genome alignments (246 core genes
shared by ≥99% of the strains). Prevalence of determinants involved in virulence is indicated by black (present) and white (absent) squares. C. coli isolates form the
gray cluster. Visualized in the interactive Tree of life tool (iTol).
Epitools was used to calculate the 95% confidence intervals (CI
95%) using the Wilson method4.
RESULTS
Genetic Diversity of the Isolates
Campylobacter jejuni was the predominant species found in
19 out of 26 (73.1%, CI 95%: 53.9–86.3%) diarrheic persons
and 15 out of 17 (88.2%, CI 95%: 65.7–96.7%) non-diarrheic
persons. The remaining isolates were identified as C. coli. MLST
analysis revealed a total of 20 STs among 26 Campylobacter
4https://epitools.ausvet.com.au/ciproportion
isolates from persons with diarrhea and 13 STs among 17
Campylobacter isolates from persons without diarrhea (Figure 1).
The majority of STs, 12/20 among diarrheic samples and 7/13
among non-diarrheic samples, occurred only once. Out of nine
STs represented by more than one isolate, the most common were
ST-50 and ST-257 among diarrheic samples [noted in both in
7.7% CI 95%: 2.1–24.1%) of isolates] and among non-diarrheic
samples (noted in 17.6%, CI 95%: 6.2–41.0% and 11.8%, CI
95%: 3.3–34.3% of isolates, respectively). Four novel STs were
identified in diarrheic samples, ST-7801 and ST-9862 in C. jejuni
and ST-7800 and ST-7801 in C. coli. Six STs were unassigned to
any clonal complex (CC, analysis April 2020). The ST-21 complex
(including 7 out of 43 isolates, 16.3%, CI 95%: 8.1–29.9%), ST-828
complex (6/43, 13.9%, CI 95%: 6.6–27.3%), and ST-257 complex
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FIGURE 2 | Neighbor-joining tree of concatenated MLST allele sequences among Campylobacter isolates originating from this study and different sources previously
reported from Poland (from the PubMLST database and Wieczorek et al., 2017; Wieczorek and Osek, 2018; Fiedoruk et al., 2019). Isolates obtained in this study are
marked by red triangles. Black-colored square indicates humans as source of the isolate(s), blue poultry, green cattle, and red pig. Dotted lines indicate C. coli
isolates; other isolates are C. jejuni. Visualized in the interactive Tree of life tool (iTol).
(6/43, 13.9%, CI 95%: 6.6–27.3%) were the largest CCs. Moreover,
the ST-828 complex, including 5 STs (ST-825, ST-1191, ST-1957,
ST-7214, and ST-7800) showed the greatest diversity.
Comparison of the STs of Campylobacter spp. isolates
obtained from different sources from Poland is shown in
Figure 2. Majority of the STs (57% for C. jejuni and 29% for
C. coli) in our study were reported previously also in poultry
isolates, and 19% and 24% of the STs for C. jejuni in cattle and
pigs, respectively. Two of the most common STs in our study,
ST-464 and ST-257, were found in all four different sources,
while ST-50 was previously detected in humans, poultry, and
swine, but not in cattle. Most of the STs for C. coli (71%) were
previously undetected from other sources in Poland. Only 38%
of the C. jejuni STs had not been previously found in other
sources in Poland.
Antimicrobial Susceptibility Testing
Overall, the highest phenotypic resistance rates were
observed for ciprofloxacin (CI 95%: 59.8–85.1%),
sulfamethoxazole/trimethoprim (CI 95%: 52.5–79.5%), and
amoxicillin (CI 95%: 43.3–71.6%), both among isolates from
diarrheic and non-diarrheic samples. Slightly lower rates of
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resistance to tetracycline (CI 95%: 34.6–63.2%) and ceftriaxone
(CI 95%: 32.5–61.1%) were noted (Table 1). Simultaneously, only
single Campylobacter isolates were resistant to macrolides (3 out
43, CI 95%: 2.4–18.6%), aminoglycosides (2 out of 43 isolates, CI
95%: 1.3–15.5%), and combination penicillin-type antibiotic (2
out of 43, CI 95%: 1.3–15.5%) (Supplementary Table S1).
Twenty three different patterns of phenotypic antimicrobial
resistance were noted in this study. None of the isolates was
resistant to all tested antimicrobial agents. Simultaneously, we
did not observe any isolate susceptible to all studied classes of
antibiotics. A total of 26 isolates (CI 95%: 45.6–73.6%) were
resistant to three or more antimicrobial agents.
Antimicrobial Resistance Genes
The presence of common antimicrobial resistance genes
among Campylobacter isolates from diarrheic and non-
diarrheic persons showed no significant differences (P > 0.05).
The overall presence of resistance-gene profiles toward
tetracyclines, fluoroquinolones, aminoglycosides, and β-lactams
among human C. jejuni and C. coli isolates is shown in
Supplementary Table S1.
Overall, a total of 40 isolates (CI 95%: 81.4–97.6%) were
positive for one of two noted β-lactamase genes, blaOXA61 or
blaOXA184. Both among isolates from humans with diarrhea and
without diarrhea, the prevailing gene was the blaOXA61 noted
in 37 out of 40 isolates (CI 95%: 80.1–97.4%). Simultaneously
among 18/37 of blaOXA61-positive isolates, the point mutation
associated with phenotypic resistance was noted and was more
common in isolates originating from 10 out of 15 non-
diarrheic persons (CI 95%: 41.7–84.8%) compared to 8 out
of 22 isolates from diarrheic persons (CI 95%: 19.7–57.1%)
(P = 0.0696). The less common blaOXA184-positive isolates
were assigned to ST-7052, ST-7801, and ST-5397, which are
closely related.
The genes associated with resistance to tetracyclines were
found among 21 out of 43 (CI 95%: 34.6–63.2%) isolates, and
simultaneously all isolates exhibited resistance to tetracycline.
Most of the isolates carried the intact tet(O) gene, but in 6
isolates from diarrheal samples (assigned to ST-464, ST-5150, ST-
7802, and ST-523) and in 3 isolates of non-diarrheal samples
(assigned to ST-4373, ST-5397, and ST-5150), the mosaic gene
tet(O/32/O) was present.
Resistance to fluoroquinolones associated with mutations in
the gyrA gene was found among 29 out of 43 of the isolates
(67.4%, CI 95%: 52.5–79.5%). The Thr-86-Ile mutation in gyrA
gene was present only in C. jejuni isolates. The phenotypic
resistance to ciprofloxacin was confirmed in 32 out of 43 isolates
(74.4%, CI 95%: 59.8–85.1%), and aminoglycoside resistance,
conferred by aadE-Cc and aph(3’)-III gene, was noted in 11.6%
(CI 95%: 5.1–24.5%) of Campylobacter isolates. The aadE-Cc
gene was found only among 2/7 C. coli isolates from diarrhea
samples, whereas the aph(3’)-III gene was present both in
C. jejuni isolates from 1 out of 19 diarrheic and 2 out of 5
non-diarrheic persons.
A high level of concordance was observed between phenotypic
and genotypic resistance for gentamicin and presence of the
aadE_Cc gene (100%), tetracycline and tet(O) or tet(O/32/O) TA
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TABLE 2 | Comparison between phenotypic and genotypic resistance in Campylobacter isolates.
Phenotypic resistance Genotypic resistance Concordance (%)
Ciprofloxacin resistance versus mutation T86I gyrA R (n = 32) R (n = 29) 93
Tetracycline versus tet(O) or tet(O/32/O) R (n = 21) R (n = 21) 100
Gentamicin versus aadE-Cc R (n = 2) R (n = 2) 100
Amoxicillin versus blaOXA61 R (n = 23) R (n = 37) 67.4
Including: Isolates with noted mutation in blaOXA61 R (n = 12) R (n = 17) 88.4
Amoxicillin versus blaOXA184 R (n = 2) R (n = 3) 97.7
(100%), and ciprofloxacin and T86I mutation in the gyrA gene
(93%) (Table 2).
To determine the erythromycin resistance, the isolates were
screened for the presence of 23S rRNA, rplV, rplD, and cmeRABC
locus mutations and for the presence of the erm(B) gene. None
of the isolates tested showed the presence of the erm(B) gene or
mutation in 23S rRNA. Overall, 35 isolates possessed substitution
in the ribosomal protein L4 (V196A) and 3 isolates possessed
substitution T91K. In regard to ribosomal protein L22 among
13 isolates, the following substitutions were noted: S13P, G74A,
A103V, T109A, A111E, A114T, T119A, A121V, and A136T.
Among 11 out of 43 (25.6%, CI 95%: 14.9–40.2%), the mutation
in the intergenic region between cmeR and cmeA was observed
including single substitution or single deletion. Further analysis
of the cmeR gene revealed that 11 out of 26 (42.3%, CI 95%:
25.5–61.1%) of isolates from diarrheic persons and 11 out of
17 (64.7%, CI 95%: 41.3–82.7%) of isolates from non-diarrheic
persons showed the presence of mutation, resulting in amino
acid changes. The most common mutation noted in isolates
from both diarrheic and non-diarrheic samples were G144D,
P183R, and S207G.
Ten different patterns were noted among antimicrobial
resistance gene content (Table 1). None of the isolates was
found to be genetically susceptible to all antimicrobials tested.
Multiresistant genotypes to at least three different antimicrobial
classes were found among 12 out of 26 of Campylobacter
isolates from diarrheic and among 6 out of 17 from non-
diarrheic samples.
Virulence Factors
All C. jejuni and C. coli isolates obtained from diarrheic and non-
diarrheic persons possessed the genes associated with adherence
(cadF, jlpA, porA, and pebA) and invasion (ciaB, flaC, and
pldA) (Figure 1).
The cdt gene cluster was confirmed to be more common
among Campylobacter spp. isolates from diarrheic samples
(25/26, 96.2%, CI 95%: 81.1–99.3%) than among isolates from
non-diarrheic samples (13/17, 76.5%, CI 95%: 52.7–90.4%)
(P = 0.071). Out of three genes associated with cytotoxin
production, the lowest prevalence was noted for the cdtC gene
(38/43, 88.4%, CI 95%: 75.5–94.9%) compared to levels observed
for cdtB (42/43, 97.7%, CI 95%: 87.9–99.6%) and cdtA (41/43,
95.5%, CI 95%: 84.5–98.7%) genes (Figure 1).
The prevalence of type IV secretion system genes (T4SS)
was slightly higher in Campylobacter isolates from non-diarrheic
persons (23.5%, CI 95%: 9.6–47.3%) than in isolates from
diarrheic persons (15.4%, CI 95%: 6.1–33.5%) (P > 0.05). Three
out of four isolates from diarrheic samples had all tested genes
(virB11, virB10, virB9, virB8, virB7, virB6, virB5, virB4, and
virD4), and all were obtained from bloody diarrhea. Isolate Be12
was positive for 7 out of 9 tested genes (virB11, virB10, virB9,
virB8, virB6, virB4, and virD4). Two out of 4 isolates obtained
from non-diarrheic persons (isolates 11p2 and Be4) were positive
for all T4SS cluster genes. Isolates Be8 and 39S were missing
virB5+ virB7 genes and virD4 gene, respectively.
The occurrence of T6SS-positive isolates among C. jejuni was
higher for diarrheic isolates 7/26 (26.9%, CI 95%: 13.7–46.1%)
than non-diarrheic isolates 2/17 (11.8%, CI 95%: 3.3–34.3%)
(P = 0.2491). 3 out of 7 Campylobacter isolates positive for T6SS
originating from diarrheal persons were obtained from stools
with the presence of blood. However, none of the isolates from
both diarrheic and non-diarrheic persons contained the entire
T6SS locus. T6SS-positive isolates showed the presence of nine
(tssJ, tssB, tssC, hcp, tssE, tssA, tssG, tagH, and tssK) out of the 13
genes described for the complete locus (Silverman et al., 2012).
Among T6SS-positive isolates from diarrheic samples, five out of
seven belonged to either ST-464 or ST-824.
DISCUSSION
Most Campylobacter strains described in various studies were
isolated from persons with diarrhea as the most common
symptom (Kovanen et al., 2014; Jelovcan et al., 2016; Ramonaite
et al., 2017). However, some infected people may have symptoms,
e.g., abdominal pain without watery or bloody diarrhea (Allos,
2001). Based on WGS, we compared Campylobacter jejuni
and C. coli isolates from diarrheic and non-diarrheic persons,
who visited their physician to seek medical advice, to better
understand the difference between strains of Campylobacter
and associated disease outcome. The division of study groups
into diarrheic and non-diarrheic humans was based on
the information given by their physician. The results also
allow a better understanding of the population structure and
antimicrobial resistance profiles of Campylobacter isolates.
Campylobacter jejuni was the most prevalent species,
among samples from persons both with diarrhea (73.1%) and
without diarrhea (88.2%). The remaining isolates were C. coli.
According to Kaakoush et al. (2015), gastroenteritis caused by
Campylobacter species is less frequently induced by C. coli than
C. jejuni but can be as high as 25% of cases. These findings are in
accordance with our data, and similar results were recently noted
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not only in Poland (Szczepan´ska et al., 2017) but also in Austria
(Jelovcan et al., 2016) and Germany (Gurtler et al., 2005).
In persons with diarrhea, both secretory (73.1%) and bloody
(26.9%) stools were observed. A similar rate of samples with the
presence of blood was observed by Tracz et al. (2005) and Quetz
et al. (2012) at levels of 27% and 30%, respectively. According to
Janssen et al. (2008), adherence of Campylobacter to the intestine
and the production of toxins, which alter the fluid resorption
capacity of the intestine, resulted in secretory diarrhea, while
bacterial invasion and replication within the intestinal mucosa
were accompanied by an inflammatory response resulting in
blood-containing inflammatory diarrhea.
Campylobacter isolates showed considerable variation in
their sequence types, irrespective of the species. In total, 26
Campylobacter isolates from diarrheic persons were assigned to
20 STs, while out of 17 isolates from non-diarrheic persons 13 STs
were found. Genetic diversity of human Campylobacter isolates
has been reported, in many geographic regions, i.e., in Lithuania
(Ramonaite et al., 2017), in Austria (Jelovcan et al., 2016),
in Finland (Kovanen et al., 2014), and in Denmark (Joensen
et al., 2018). Moreover, in the present study, the majority of
STs (67.9%) were represented by a single isolate, underlining
the non-epidemic background of the Campylobacter infections.
In our study, ST-50 and ST-257 were the most common. These
STs have been described as prevailing both in humans (Mossong
et al., 2016; Elhadidy et al., 2018) and in poultry (Dearlove et al.,
2016; Wieczorek et al., 2017) in different geographical regions.
Majority of the STs (57% for C. jejuni and 29% for C. coli)
in our study, however, have been reported previously not only
in poultry isolates but also from cattle and pigs. For example,
ST-429, noted in the current study both from diarrheic and non-
diarrheic persons, belongs to CC-48, which has been frequently
connected with cattle (An et al., 2018; Wieczorek and Osek,
2018). The most common STs in our study, ST-464, ST-257,
and ST-50, have been identified in multiple sources in Poland
and elsewhere, supporting the evidence that the most successful
strains are able to colonize several host species and thus are also
more widespread in the food chain and the environment.
Resistance against β-lactams is high among Campylobacter
isolates, and majority of them, irrespective of geographical
regions, produce beta-lactamases (Wieczorek and Osek, 2013;
Reddy and Zishiri, 2017; Redondo et al., 2019). Similarly, in this
study the most common antimicrobial resistance determinants
were beta-lactamase genes, blaOXA61 and blaOXA184. However,
Griggs et al. (2009) underlined that the role of β-lactamase genes
in the mechanism of resistance to ampicillin in campylobacters
are not yet clear, and the production of β-lactamase is not always
associated with resistance to β-lactams.
In this study, 15 out of 40 (CI 95%: 37.5–52.9%) isolates
possessing the blaOXA gene were sensitive to amoxicillin.
Similar results were noted by Aslantas¸ (2017) who confirmed
susceptibility to ampicillin in 14.9% of C. jejuni and 32.5%
of C. coli isolates that harbored this marker. Zeng et al.
(2014) underlined that some C. jejuni strains that carry the
β-lactamase genes blaOXA61 are still susceptible to β-lactams
with undetected β-lactamase activity, suggesting that a point
mutation (G→T transversion) upstream blaOXA61 conferred
high-level ampicillin resistance in Campylobacter strains. In our
study, altogether 70.6% (12 out of 17 isolates) of Campylobacter
isolates with confirmed presence of the single-nucleotide
mutation upstream of the blaOXA61 gene were resistant to
amoxicillin. The observed resistance levels were significantly
higher among isolates with confirmed mutation (83.3% of
isolates showed the MIC values ≥ 128 µg/ml) compared to
isolates without the mutation (30.8% of isolates showed the MIC
values≥ 128 µg/ml). Interestingly the combination of penicillin-
type antibiotic (AMP, amoxicillin/clavulanic) was highly effective
against Campylobacter (resistance exhibited by 2 out 43 isolates,
CI 95%: 1.3–15.5%).No resistance to amoxicillin–clavulanic acid
was detected by Post et al. (2017) in Belgium and Wallace et al.
(2019) in Australia in clinical isolates. Also, the study conducted
by Schiaffino et al. (2019) provides compelling evidence to
propose amoxicillin/clavulanic acid as an effective treatment for
campylobacteriosis.
The fluoroquinolones, as broad-spectrum antimicrobials,
are frequently used especially in treatment of undiagnosed
cases of diarrhea (Sproston et al., 2018). In this study, high
numbers of isolates with gyrA T86I mutation associated with
fluoroquinolone resistance occurred in isolates from both
diarrheic and non-diarrheic samples (69.2% and 64.7% of
isolates, respectively). This finding is in accordance with other
Polish data published by Roz˙ynek et al. (2008), who reported
this mutation in 59.2% of human Campylobacter isolates. Also,
recently published data from Poland presented by Szczepan´ska
et al. (2017) and Wieczorek et al. (2018) showed a rising trend
in resistance to these antibacterial agents. Furthermore, we noted
the significantly marked correlation between phenotypic and
genotypic resistance to fluroquinolones. Of 32 isolates exhibiting
the resistance to ciprofloxacin, 29 (90.6%, CI 95%: 75.8–96.8%)
possessed T86I mutation in the gyrA gene. The 3 isolates
lacking the Thr-86-Ile amino acid substitution showed low-level
resistance to ciprofloxacin (1 µg/ml), and all belonged to C. coli.
These isolates exhibited other amino acid substitutions at codon
22, 237, or 285, which also occurred among isolates susceptible
for CIP; therefore, their role in resistance is unlikely to be
important. Charvalos et al. (1996) described other mechanisms
of resistance to quinolones including decreased outer-membrane
permeability and efflux systems, which may contribute to the
phenotypic resistance observed in strains, where no mutations
leading to amino acid changes in gyrA were observed. Similarly,
a high level of correlation was observed between genotypic and
phenotypic resistance against tetracyclines. Altogether, the tet(O)
gene or a mosaic gene tet(O/32/O) was detected in 50% of the
isolates from diarrheic persons and in 47.1% of isolates from non-
diarrheic persons and all of these isolates exhibited phenotypic
resistance to tetracycline. Also, data presented by Reddy and
Zishiri (2017) revealed a wide distribution of the tet(O) gene
in 64% of human clinical isolates. The studies conducted by
Wieczorek et al. (2018) in Poland showed high phenotypic
resistance to tetracyclines among human isolates at the level of
70.3%. Lopes et al. (2019) showed the prevalence of mosaic form
of the tet(O) gene among Campylobacter isolates belonging to
CC-464 in the United Kingdom. Also in this study, the mosaic
gene tet(O/32/O) was noted in all C. jejuni isolates belonging to
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ST-464, indicating a wider dispersion of this resistant genotype
in Europe. Our findings are in accordance with previously
presented data showing high resistance rates to tetracyclines
and fluoroquinolones (Szczepan´ska et al., 2017; Wieczorek et al.,
2018), rendering these antimicrobials not useful in treatment of
campylobacteriosis.
Only a few Campylobacter isolates possessed genes associated
with aminoglycoside (e.g., gentamicin or streptomycin)
resistance (approximately 11% had aph(3’)-III or aadE-
Cc genes). However, previous studies have shown that the
prediction of resistance against aminoglycosides is not always
straightforward from WGS data using currently available tools
(Meistere et al., 2019). In this study, the obtained phenotypic rate
of resistance to gentamicin was slightly lower compared to the
genotypic rate, confirmed in 2 out of 43 isolates (CI 95%: 1.3–
15.5%). All gentamicin-resistant isolates possessed the aadE_Cc
gene. Three isolates with the aph(3’)-III gene were susceptible
to gentamicin. Generally, the distribution of aphA genes in
clinical Campylobacter isolates confers resistance to kanamycin
(Cameron and Gaynor, 2014). Also in previous studies, mostly
low levels of resistance to this class of antimicrobials, using
gentamicin as a model, were shown (Roz˙ynek et al., 2008;
Szczepan´ska et al., 2017).
In our study, none of the Campylobacter isolates, irrespective
of the species, displayed a mutation in the 23S rRNA gene,
resulting in macrolide resistance. Similarly, in previous studies
conducted in Poland, very low resistance to macrolides was
detected among human Campylobacter isolates (Roz˙ynek et al.,
2008; Szczepan´ska et al., 2017). According to Luangtongkum
et al. (2009), several modifications in the ribosomal proteins L4
and L22 are associated with low- to intermediate-level macrolide
resistance in Campylobacter. Mutations in the large loop of the L4
protein (residues 55 to 77) and the L22 protein (residues 78 to 98)
have been confirmed to be associated with macrolide resistance
in various bacteria (Zhou et al., 2016). In this study, no variations
were found in these regions. The ribosomal RNA methylase gene
ermB represents a major mechanism for macrolide resistance
(Zhou et al., 2016); however, this marker was not reported
in any of the isolates. Wieczorek and Osek (2013) draw
attention to the presence of CmeABC multidrug efflux pump,
which is the major efflux mechanism causing antimicrobial
resistance to several antimicrobials including fluoroquinolones
and macrolides. Expression of cmeABC operon is controlled
by a transcriptional repressor named CmeR (Lin et al., 2005).
Mutations observed in the cmeR gene or in the inverted repeat
(IR) region of the efflux operon result in enhanced resistance
to different groups of antimicrobials agents. In this study, a
mutation in the cmeR gene was noted in 51.2% isolates, while
25.6% were positive for mutation in the intergenic region
between cmeR and cmeA genes. Interestingly, the antimicrobial
susceptibility testing performed in this study revealed the
occurrence of resistance to erythromycin in 3 out of 43 tested
isolates (CI 95%: 2.4–18.6%) and all these isolates possessed both
three or more mutations in the cmeR gene resulting in changes
of aa and mutation in the IR region. Interestingly, isolate Be3
with the highest resistance to ERY (>256 µg/ml) did not have
the complete sequence for transcriptional regulatory gene cmeR
(633 bp). A deletion of 122 bp was noted, resulting in a premature
stop codon in the gene, encoding a truncated 176-amino acid
product instead of the full 211-amino acid protein.
In this study, high rates of resistance were also found in
ceftriaxone and trimethoprim/sulfamethoxazole, at the levels
46.5% (CI 95%: 32.5–61.1%) and 67.4% (CI 95%: 52.5–79.5%),
respectively. Emonet et al. (2017) suggest that ceftriaxone
is often prescribed empirically for patients hospitalized with
abdominal pain and fever. However, in many studies this
antimicrobial agent is not recommended for treatment of
campylobacterisosis (Emonet et al., 2017; Schiaffino et al., 2019).
Similarly, trimethoprim/sulfamethoxazole is not recommended
to be used in routine treatment of campylobacteriosis. Studies in
Taiwan (Chang et al., 2017) or Thailand (Mason et al., 2017) show
high incidence of SXT resistance in Campylobacter, suggesting
that this type of resistance is actual if these antimicrobials
are used. Simultaneously, we noted that the majority of the
isolates exhibiting resistance to ceftriaxone (65%, CI 95%: 43.3–
81.9%) and trimethoprim/sulfamethoxazole (68.9%, CI 95%:
50.8–82.7%) possessed mutations in the cmeR gene or in
the inverted repeat region, previously shown to result in the
overexpression of CmeABC and enhanced resistance to multiple
antibiotics (Lin et al., 2005). Multidrug resistance (MDR), defined
as resistance to three or more classes of antimicrobial agents, is
an emerging problem among pathogenic bacteria (Schwarz et al.,
2010). We found a relatively high number of C. jejuni isolates
which harbor resistance genes against at least three antimicrobial
classes (38.2% of strains). In addition, three C. jejuni isolates
had a combination of four genes associated with resistance
(gyrA, tet(O), blaOXA, and aph) increasing the total percentage
of multiresistant isolates up to 47.1%. When considering the
phenotypic resistance, MDR was noted in 55.8% of the isolates.
Simultaneously, data presented in different geographical regions
showed high and extremely high prevalence of MDR among
Campylobacter isolates (Schiaffino et al., 2019). Further analysis
revealed that all isolates assigned to ST-257, ST-429, ST-
464, ST-572, and ST-824 were associated with multiresistance.
Especially, ST-464 seems to have acquired multiresistance all over
Europe. Among Campylobacter strains assigned to ST-464, the
multidrug resistance to ciprofloxacin, nalidixic acid, tetracycline
ciprofloxacin, tetracycline, and ceftriaxone was confirmed in the
studies conducted, e.g., by Cha et al. (2016) in United States and
Aksomaitiene et al. (2019) in Lithuania. Moreover, Cha et al.
(2016) underlined the need to enhance surveillance efforts and
identify factors associated with global spread of this resistant
sequence type, especially because the majority of the ST-464
isolates were obtained from individuals in United States with a
history of foreign travel. Interestingly, this sequence type was
identified only among samples from diarrheic persons.
We also assessed the differences in the prevalence of virulence
determinants. In pathogenesis, adhesion is a crucial step prior
to invasion and secretion of toxins (Letourneau et al., 2011).
All Campylobacter isolates from humans both with and without
diarrhea were shown to have the genes encoding proteins
involved in adhesion (cadF, porA, jlpA, and pebA), and invasion
(ciaB, pldA, and flaC). These findings are in accordance with
studies conducted by Biswas et al. (2011) in Canada and
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Wieczorek et al. (2018) in Poland, showing high prevalence
of these genes among clinical samples. Thus, the ability of
Campylobacter isolates to adhere to and invade epithelial cells
seems to be common.
Another important virulence factor of Campylobacter spp.
is the ability to produce toxins. The best-characterized toxin
attributed to Campylobacter is cytolethal distending toxin (CDT)
encoded by three adjacent genes cdtA, cdtB, and cdtC (Bang
et al., 2003). Many studies have shown that the cdt gene cluster
is common in human (Redondo et al., 2019), poultry (Wieczorek
et al., 2018), and cattle and swine isolates (Wysok et al., 2015).
Overall, in this study, the cdtABC gene complex was noted in
96.2% of Campylobacter isolates from persons with diarrhea. In
turn, the prevalence of the complete cdtABC gene cluster was
much lower (76.5%) among Campylobacter isolates from persons
without diarrhea.
Campylobacter isolates have two known secretion systems—
type IV secretion system (T4SS) and type VI secretion system
(T6SS). The T4SS is encoded by plasmid pVir, important for
both adherence and invasion of Campylobacter in intestinal
epithelial cells (Tracz et al., 2005). In our study, T4SS was
confirmed to be present in both Campylobacter isolates from
diarrheic samples (15.4%) and non-diarrheic samples (23.5%),
suggesting higher occurrence of the pVir plasmid than noted
in some other geographical regions, for example, 3% in the
Netherlands (Louwen et al., 2006), 10% in Thailand (Bacon
et al., 2000), and 17% in Canada (Tracz et al., 2005). The
significant role of the pVir plasmid in the development
of symptoms observed during Campylobacter infection was
underlined by Tracz et al. (2005). These authors noted
that patients infected with a pVir-positive Campylobacter
strain were more likely to produce bloody stool than those
infected with a pVir-negative strain. Louwen et al. (2006),
however, reported the absence of an association with the pVir
plasmid in patients infected with Campylobacter who developed
bloody diarrhea.
T6SS has also been shown to be an important determinant
in adhesion and invasion, and it is active in contact-
dependent transfer of DNA and proteins from bacteria to
host cells (Chen et al., 2019). Controversial results have been
presented also on the association of T6SS with the severity
of symptoms. Harrison et al. (2014) reported that patients
infected with T6SS-positive Campylobacter experienced bloody
diarrhea more frequently than those infected with T6SS-
negative Campylobacter. Moreover, these authors noted diverging
prevalence rates of this determinant in different geographical
regions, 2.6% in the United Kingdom, 15.4% in Pakistan, 33.3%
in Thailand, and 60.6% in Vietnam. In our study, this locus
was found more often in diarrheic samples (26.9%). However,
none of the Campylobacter isolates possessed the entire T6SS
cluster (13 ORFs). We noted lack of tssL and tssM genes encoding
inner membrane proteins and lack of the tssI gene encoding
VgrG protein that functions as a puncturing device toward the
targeted cells (Silverman et al., 2012). However, all T6SS-positive
Campylobacter isolates possessed the hcp gene highlighted by
Corcionivoschi et al. (2015) as an indicative component of a
functional T6SS in C. jejuni.
CONCLUSION
Whole-genome sequencing analysis showed high ST genotype
diversity of Campylobacter isolates from both diarrheic and
non-diarrheic samples. Most common STs (ST-50 and ST-257)
occurred in both groups. Nearly half of the isolates had both a
resistant genotype and phenotype to at least two antimicrobial
agents, and multidrug resistance was also common among
the isolates. Especially interesting was ST-464 with resistance
genes to tetracycline, fluoroquinolone, and beta-lactamase. This
resistant genotype seems to be common all over Europe.
We observed a higher prevalence of CDT and T6SS among
isolates from diarrheic persons, yet further studies are needed
to determine their impact on the outcome of Campylobacter
infections in more detail.
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